Foxo technologies formalizes license agreement with kr8.ai to power new epigenetic wellness solutions

Minneapolis--(business wire)--foxo technologies inc. (nyse american: foxo) (“foxo” or the “company”), a leader in the field of commercializing epigenetic biomarker technology, today announced it has formalized its collaboration with kr8.ai inc. (“kr8”) and secured the exclusive license to kr8's ai-based software to support the development and commercial launch of its new health and wellness offering - the vithar™ ai health coach. as previously announced, the company is in the process of launchi.
FOXO Ratings Summary
FOXO Quant Ranking